ADAR1 Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

ADAR1 Capital Management’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-174,715	Closed	-$708K	–	299
2023 Q4	$708K	Buy	+174,715	New	+$533K	0.25%	52

ADAR1 Capital Management's THRX Position: Q1 2024 in Review

ADAR1 Capital Management sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 174,715 shares — an estimated $708K sold.

ADAR1 Capital Management first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $708K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

ADAR1 Capital Management reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
ADAR1 Capital Management sold 174,715 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $708K.
ADAR1 Capital Management first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
ADAR1 Capital Management's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $708K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on ADAR1 Capital Management's 13F filing for Q1 2024, filed 15 May 2024.